Does PEMBROLIZUMAB Cause Intestinal obstruction? 201 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 201 reports of Intestinal obstruction have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
201
Reports of Intestinal obstruction with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
30
Deaths
135
Hospitalizations
How Dangerous Is Intestinal obstruction From PEMBROLIZUMAB?
Of the 201 reports, 30 (14.9%) resulted in death, 135 (67.2%) required hospitalization, and 30 (14.9%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
Yes, Intestinal obstruction is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which PEMBROLIZUMAB Alternatives Have Lower Intestinal obstruction Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G